BlackRock
AGN

BlackRock’s Allergan Inc AGN Stock Holding History

BlackRock’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-13,200
Closed -$1.64M – 3340
2014
Q1 		$1.64M Buy
+13,200
New +$1.61M ﹤0.01% 1085

Other funds holding AGN

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
CA
Commerzbank Aktiengesellschaft Frankfurt, Germany $4.78B AUM 25.31% 1-Year Est. Return
ECM
Everence Capital Management Goshen, Indiana $1.64B AUM 26.46% 1-Year Est. Return
HFS
HL Financial Services Louisville, Kentucky $6.5B AUM 9.56% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

BlackRock's AGN Position: Q1 2015 in Review

BlackRock sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 844,078 shares — an estimated $179M sold.

BlackRock first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $261M in Q3 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • BlackRock reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
  • BlackRock sold 844,078 Allergan Inc shares in Q1 2015, an estimated $179M.
  • BlackRock first reported a position in Allergan Inc in Q2 2013 and held it in 7 quarters.
  • BlackRock's Allergan Inc position peaked at $261M in Q3 2014.
  • 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on BlackRock's 13F filing for Q1 2015, filed 13 May 2015.